TITLE

Prophylactic hemodialysis after coronary angiography improved renal outcomes in patients with advanced renal failure

AUTHOR(S)
Romanovsky, Adam; Pannu, Neesh
PUB. DATE
March 2008
SOURCE
ACP Journal Club;Mar/Apr2008, Vol. 148 Issue 2, p17
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on the randomized controlled trial (RCT) investigating if prophylactic hemodialysis after coronary angiography prevents contrast-induced nephropathy (CIN) in patients with advanced renal failure. The trial, conducted with 90 patients (20 years of age) found out that in patients with advanced renal failure, prophylactic hemodialysis after coronary angiography maintained creatinine clearance and reduced risk for permanent renal damage.
ACCESSION #
32435140

 

Related Articles

  • NON-DIALYTIC MANAGEMENT. Tigert, Judy // CANNT Journal;Apr-Jun2004, Vol. 14 Issue 2, p40 

    Presents the results of a study on the factors that influence the recommendation of palliative treatment for patients approaching end-stage renal failure in Great Britain. Characteristics of patients who were recommended to undergo palliative treatment; Survival rate of patients who opted for...

  • Intravenous iron therapy in non-dialysis CKD patients. Macdougall, Iain C. // Nephrology Dialysis Transplantation;Apr2014, Vol. 29 Issue 4, p717 

    No abstract available.

  • Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D. Marckmann, Peter; Agerskov, Hanne; Thineshkumar, Sasikala; Bladbjerg, Else-Marie; Sidelmann, Johannes J.; Jespersen, Jørgen; Nybo, Mads; Rasmussen, Lars M.; Hansen, Ditte; Scholze, Alexandra // Nephrology Dialysis Transplantation;Sep2012, Vol. 27 Issue 9, p3523 

    Background Hypovitaminosis D is common in chronic kidney disease (CKD). Effects of 25-hydroxyvitamin D replenishment in CKD are not well described. Methods An 8-week randomized, placebo-controlled, double-blind parallel intervention study was conducted in haemodialysis (HD) and non-HD CKD...

  • Pharmacokinetic and Pharmacodynamic Profile of Rosuvastatin in Patients with End-Stage Renal Disease on Chronic Haemodialysis. Birmingham, Bruce; Swan, Suzanne; Puchalski, Tom; Mitchell, Pat; Azumaya, Connie; Zalikowski, Julie; Wang, Yi // Clinical Drug Investigation;2013, Vol. 33 Issue 4, p233 

    Background: Rosuvastatin has been shown to provide effective treatment of dyslipidaemia in patients with end-stage renal disease (ESRD) undergoing haemodialysis, but data from controlled trials are very limited on the pharmacokinetics and pharmacodynamics of rosuvastatin in this population....

  • Effect of Information and Telephone-Guided Access to Community Support for People with Chronic Kidney Disease: Randomised Controlled Trial. Blakeman, Tom; Blickem, Christian; Kennedy, Anne; Reeves, David; Bower, Peter; Gaffney, Hannah; Gardner, Caroline; Lee, Victoria; Jariwala, Praksha; Dawson, Shoba; Mossabir, Rahena; Brooks, Helen; Richardson, Gerry; Spackman, Eldon; Vassilev, Ivaylo; Chew-Graham, Carolyn; Rogers, Anne // PLoS ONE;Oct2014, Vol. 9 Issue 10, p1 

    Background: Implementation of self-management support in traditional primary care settings has proved difficult, encouraging the development of alternative models which actively link to community resources. Chronic kidney disease (CKD) is a common condition usually diagnosed in the presence of...

  • The ultimate salt war? Uraemic toxins are all that count in dialysis patients. Vanholder, Raymond // Nephrology Dialysis Transplantation;Jan2012, Vol. 27 Issue 1, p62 

    No abstract available.

  • Convective therapies versus low-flux hemodialysis for chronic kidney failure: a meta-analysis of randomized controlled trials. Susantitaphong, Paweena; Siribamrungwong, Monchai; Jaber, Bertrand L. // Nephrology Dialysis Transplantation;Nov2013, Vol. 28 Issue 11, p2859 

    Background Although convective therapies have gained popularity for the optimal removal of uremic solutes, their benefits and potential risks have not been fully elucidated. We conducted a meta-analysis of all randomized controlled trials comparing convective therapies with low-flux hemodialysis...

  • Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures. Onbasili, Alper O.; Yeniceriglu, Yavuz; Agaoglu, Pinar; Karul, Asluhan; Tekten, Tarkan; Akar, Harun; Discigil, Guzel // Heart;Jun2007, Vol. 93 Issue 6, p698 

    Objective: To evaluate the efficacy of trimetazidine (TMZ) in the prevention of contrast-induced nephropathy (CIN) in patients with high serum creatinine levels undergoing coronary angiography/angioplasty. Methods: TMZ (20 mg thrice daily) was administered orally for 72 h starting 48 h before...

  • Uremic Toxins and Lipases in Haemodialysis: A Process of Repeated Metabolic Starvation. Stegmayr, Bernd // Toxins;May2014, Vol. 6 Issue 5, p1505 

    Severe kidney disease results in retention of uremic toxins that inhibit key enzymes for lipid breakdown such as lipoprotein lipase (LPL) and hepatic lipase (HL). For patients in haemodialysis (HD) and peritoneal dialysis (PD) the LPL activity is only about half of that of age and gender matched...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics